Cardiovascular comorbidity in multiple sclerosis patients treated with Mitoxantrone therapy: a cohort study
Mitoxantrone (MX) has been used as second line therapy for aggressive multiple sclerosis (MS). Potential cardiotoxic effects of MX limit its use; a cumulative dose of up to 100 mg/m2, has been long considered ...
Multiple Sclerosis and Demyelinating Disorders 2017 2:12
Published on: 24 July 2017